Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke
- 30 June 2009
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 204 (2), e58-e63
- https://doi.org/10.1016/j.atherosclerosis.2008.10.011
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery diseaseAtherosclerosis, 2008
- LeukotrienesNew England Journal of Medicine, 2007
- Cyclooxygenase Polymorphisms and Risk of Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) StudyClinical Pharmacology & Therapeutics, 2007
- Vascular wall–produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptorsThe Journal of Experimental Medicine, 2007
- Genetic Variants of Arachidonate 5-Lipoxygenase–Activating Protein, and Risk of Incident Myocardial Infarction and Ischemic StrokeStroke, 2006
- Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case–control approachJournal of Thrombosis and Haemostasis, 2006
- Simple estimates of haplotype relative risks in case‐control dataGenetic Epidemiology, 2006
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke PatientsStroke, 2005
- Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish PopulationAmerican Journal of Human Genetics, 2005